Ophthalmologic Manifestations of Botulism Clinical Presentation

  • Author: Bhupendra Patel, MD, FRCS; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Feb 15, 2012
 

History

The diagnosis of botulism requires a high degree of clinical suspicion. Although laboratory confirmation is required, the diagnosis should be suspected on clinical findings, in those patients with an appropriate history and physical (particularly neurologic) examination.

  • Food poisoning
    • The severity of illness varies from a mild condition to a very serious disease with death within 24 hours. The incubation period is generally 18-36 hours; however, it may vary from several hours to several days.
    • The initial symptoms are usually those of motor cranial nerve involvement with onset of diplopia, dysphonia, and dysphagia. A generally symmetric descending paralysis follows. Abdominal pain, with nausea and vomiting may precede or follow paralysis. A dry mouth and throat reflect cholinergic parasympathetic disturbance. Patients generally remain alert and responsive. Sensory deficits, besides blurred vision, have been reported only in rare cases.
  • Wound infection[7]
    • The incubation period averages about 7 days. Wound botulism may occur in any wound contaminated by soil or water.
    • Symptoms are generally the same as those seen in food-borne botulism, except gastrointestinal symptoms are absent. The source wound may appear relatively benign. Wound infections associated with intravenous drug needle puncture sites are becoming an important cause.
  • Infant botulism[8]
    • The incubation period varies from 3-30 days. In this form of botulism, the severity ranges from mild illness with failure to thrive to severe paralysis with respiratory failure.
    • Infant botulism causes acute bulbar dysfunction. The first sign of the disease may be constipation. Other features include lethargy, hypotonia with poor head control, poor feeding, with difficulty in sucking and swallowing, and pooled oral secretions. Respiratory failure occurs in up to one half of diagnosed infants.
    • The identification of contaminated honey as a source of spores has lead to the recommendation that honey should not be given to infants younger than 1 year. Susceptibility decreases with age as the normal intestinal flora develops.
Next

Physical

The major systemic features of botulism involve motor weakness or paralysis. Paralysis begins with cranial nerve involvement and progresses caudally to involve extremities.

  • Clinical physical findings involve the following:
    • Symptoms of motor cranial nerve involvement with onset of dysarthria, dysphonia, and dysphagia may be present.
    • A generally symmetric descending paralysis occurs, with involvement of neck, arms, thorax, and legs.
    • Respiratory difficulties occur with intercostal and diaphragmatic weakness.
    • Autonomic features are to be expected, reflecting cholinergic neurotransmission disruption, with impairment of salivary secretion, paralytic ileus, constipation, and urinary retention.
    • Postural hypotension may be present.
    • The gag reflex may be suppressed.
    • Typically, patients are afebrile.
  • Ophthalmic manifestations may reflect the anticholinergic effects of the neurotoxins.
    • Accommodation paresis, with blurred vision
    • Pupil dysfunction with mydriasis and poorly reactive pupils
    • Dry eye symptoms with impairment of lacrimation
  • Ophthalmic manifestations may reflect a deficit at the neuromuscular junction.[9, 10]
    • Oculoparesis or ophthalmoplegia manifests as diplopia.
    • Blepharoptosis is common.
    • Nystagmus may be noted.
  • Ocular manifestations may be the manifesting features of botulism. However, their absence does not exclude this disease, since the various toxins appear to involve the ocular system to various degrees. Neurotoxin A may have no specific ophthalmic manifestations.
  • In wound botulism, the symptoms are generally the same as those seen in food-borne botulism, except gastrointestinal symptoms are lacking.
  • In the infant, the clinical examination may note neurologic features of ptosis, ophthalmoplegia, weak gag reflex, and poorly reactive pupils, in addition to systemic features of generalized muscle weakness with hypotonia and a weak cry.
Previous
Next

Causes

Botulism is a disease caused by the neurotoxins of C botulinum.

Previous
 
 
Contributor Information and Disclosures
Author

Bhupendra Patel, MD, FRCS  Professor of Ophthalmic Plastic and Facial Cosmetic Surgery, Department of Ophthalmology and Visual Sciences, John A Moran Eye Center, University of Utah School of Medicine

Bhupendra Patel, MD, FRCS is a member of the following medical societies: American Academy of Ophthalmology, American Society of Ophthalmic Plastic and Reconstructive Surgery, Royal College of Surgeons of England, and Royal Society of Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Simon F Taylor, MBBS, FRANZCO, FRACS  Clinical Senior Lecturer, Oculoplastic Surgery, Save Sight Institute, University of Sydney, Australia

Simon F Taylor, MBBS, FRANZCO, FRACS is a member of the following medical societies: Australian Medical Association and Royal Australasian College of Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

Andrew W Lawton, MD  Medical Director of Neuro-Ophthalmology Service, Section of Ophthalmology, Baptist Eye Center, Baptist Health Medical Center

Andrew W Lawton, MD is a member of the following medical societies: American Academy of Ophthalmology, Arkansas Medical Society, and Southern Medical Association

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD  Associate Professor of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Brian R Younge, MD  Professor of Ophthalmology, Mayo Clinic School of Medicine

Brian R Younge, MD is a member of the following medical societies: American Medical Association, American Ophthalmological Society, and North American Neuro-Ophthalmology Society

Disclosure: Nothing to disclose.

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Laskawi R. The use of botulinum toxin in head and face medicine: an interdisciplinary field. Head Face Med. Mar 10 2008;4:5. [Medline].

  2. Fach P, Micheau P, Mazuet C, Perelle S, Popoff M. Development of real-time PCR tests for detecting botulinum neurotoxins A, B, E, F producing Clostridium botulinum, Clostridium baratii and Clostridium butyricum. J Appl Microbiol. Mar 9 2009;[Medline].

  3. Hatheway CL. Botulism: the present status of the disease. Curr Top Microbiol Immunol. 1995;195:55-75. [Medline].

  4. Domingo RM, Haller JS, Gruenthal M. Infant botulism: two recent cases and literature review. J Child Neurol. Nov 2008;23(11):1336-46. [Medline].

  5. Mitchell WG, Tseng-Ong L. Reviews of infant botulism at childrens hospital los angeles. J Child Neurol. Aug 2008;23(8):968. [Medline].

  6. Centers for Disease Control and Prevention. Botulism in the United States, 1899-1996. Handbook for epidemiologists, clinicians, and laboratory workers. Atlanta, Ga: 1998:1-43. [Full Text].

  7. Teismann IK, Steinstraeter O, Warnecke T, et al. Cortical recovery of swallowing function in wound botulism. BMC Neurol. May 7 2008;8:13. [Medline].

  8. Domingo RM, Haller JS, Gruenthal M. Infant botulism: two recent cases and literature review. J Child Neurol. Nov 2008;23(11):1336-46. [Medline].

  9. König H, Gassman HB, Jenzer G. Ocular involvement in benign botulism B. Am J Ophthalmol. Sep 1975;80(3 Pt 1):430-2. [Medline].

  10. Albert DM, Jakobiec FA. Systemic bacterial infections and the eye. In: Ryan ET, Sullivan BA, eds. Principles and Practice of Ophthalmology: Clinical Practice. WB Saunders Co; 1994:3006-10.

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.